Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHARTWELL RX

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

PRINSTON INC

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 34
  • 0 comments

FDA approve DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 41
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

WATSON LABS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 35
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 31
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

HERITAGE PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 34
  • 0 comments

FDA approve METOPROLOL TARTRATE

Comment Full text
  • Previous
  • 317
  • 318
  • 319
  • 320
  • 321
  • Next

Search

News categories

  • Technical Exchange News(10620)
  • Event(2032)
  • SEC News(185163)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122569)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin